Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial of LY3023414 for recurrent or persistent endometrial cancer has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) [Phase 1, Phase 2]
Open-label, dose-escalation study of pemigatinib in advanced malignancies (FIGHT-101) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of Enapotamab Vedotin in solid tumors, including ovarian and cervical cancer; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer [Phase 3]
Phase 3 trial evaluating short-course vaginal cuff brachytherapy for stage I–II endometrial cancer is currently recruiting. Results were pos…
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer [Phase 2]
A Phase 2 trial evaluating letrozole in combination with RAD001 (everolimus) for advanced or recurrent endometrial cancer; the study status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions [Phase 3]
Phase 3 trial evaluating molecular classification and traditional risk stratification to guide adjuvant radiotherapy decisions in early-stag…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients [Phase 2, Phase 3]
Phase 2/3 trial comparing medroxyprogesterone acetate to LNG-IUS for fertility-sparing management in early-stage endometrioid carcinoma and …
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing chemotherapy versus chemoradiotherapy for post-operative endometrial cancer patients with P53 mutation; cu…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Tachosil for the Prevention of Symptomatic Lymph Cysts [Phase 3]
Phase 3 trial update on Tachosil for prevention of symptomatic lymph cysts in gynecologic cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors [Phase 2]
Phase 2 trial evaluating famitinib plus anti-PD1 therapy for advanced renal cell carcinoma, urothelial carcinoma, and gynecologic cancers su…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 endometrial cancer trial for recurrent or persistent disease has been terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer [Phase 2]
Phase 2 trial evaluating the levonorgestrel-releasing intrauterine system for complex atypical endometrial hyperplasia or early-stage endome…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer [Phase 3]
Phase 3 trial comparing external-beam radiation therapy to vaginal brachytherapy after surgery for stage I endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bupropion hydrochloride to improve sexual desire in women with breast or gynecologic cancers has completed…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma [Phase 2]
A Phase 2 clinical trial update for ONC201 in recurrent/refractory metastatic breast cancer and advanced endometrial carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion [EARLY_Phase 1]
Early-phase clinical trial evaluating fluorescein visualization to detect invasion in endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Pembro/Carbo/Taxol in Endometrial Cancer [Phase 2]
Phase 2 trial investigating pembrolizumab, carboplatin, and paclitaxel in endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer [Phase 2]
Phase 2 clinical trial update evaluating intraoperative pathological evaluation for surgical treatment and staging in endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) [Phase 3]
Phase 3 trial MK-3475-775 evaluated lenvatinib plus pembrolizumab versus treatment of physician's choice in advanced endometrial cancer; res…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy [Phase 2]
Phase 2 trial of PM00104 (Zalypsis) in advanced/metastatic endometrial or cervical cancer previously treated with one line of chemotherapy w…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial investigating LNG-IUS as a fertility-preserving treatment for endometrial cancer and atypical endometrial hyp…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer [Phase 2]
Phase 2 clinical trial update on pembrolizumab with radiation and an immune modulatory cocktail in cervical and endometrial/uterine cancers …
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients [Phase 2]
Phase II open-label trial evaluating niraparib in combination with anti-PD1 antibody for recurrent/advanced endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) [Phase 2]
Phase 2 trial evaluating ATG 008 (dual mTORC1/2 inhibitor) or ATG-010 (selective exportin 1 inhibitor) in combination with chemotherapy for …
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback [NA]
A completed clinical trial evaluating activity monitors and tailored feedback for endometrial cancer survivors; results posted in 2021.